| |
| |
|
| Insider
Information: |
Ho Carole |
| Relationship: |
Chief Medical Officer |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
143,605 |
|
|
Indirect Shares
|
208,219 |
|
|
| Direct
Value |
$2,976,932 |
|
|
|
Indirect Value
|
$4,316,380 |
|
|
| Total
Shares |
351,824 |
|
|
| Total
Value |
$7,293,312 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
13
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
11
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 30.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Denali Therapeutics Inc. |
DNLI |
Chief Medical Officer |
2024-02-14 |
143,605 |
2024-02-14 |
208,219 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
108 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2020-08-21 |
4 |
D |
$32.88 |
$64,248 |
D/D |
(1,954) |
6,511 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2018-11-15 |
4/A |
OE |
$5.28 |
$64,601 |
I/I |
12,235 |
195,625 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-08-14 |
4 |
AS |
$23.79 |
$65,851 |
I/I |
(2,768) |
182,809 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-08-10 |
4 |
S |
$24.15 |
$68,997 |
I/I |
(2,857) |
185,577 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-12-23 |
4 |
AS |
$20.01 |
$69,315 |
D/D |
(3,464) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-02-04 |
4 |
AS |
$18.49 |
$72,015 |
D/D |
(3,869) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-05-09 |
4 |
AS |
$22.83 |
$73,438 |
I/I |
(3,210) |
107,122 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-05-10 |
4 |
AS |
$22.16 |
$73,483 |
I/I |
(3,316) |
103,806 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-05-08 |
4 |
AS |
$23.51 |
$74,339 |
I/I |
(3,162) |
110,332 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-01-05 |
4 |
AS |
$28.44 |
$74,968 |
I/I |
(2,636) |
180,364 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-02-13 |
4 |
AS |
$30.10 |
$76,695 |
I/I |
(2,548) |
184,285 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2022-08-23 |
4 |
AS |
$31.98 |
$77,520 |
I/I |
(2,424) |
170,663 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-01-04 |
4 |
S |
$28.69 |
$83,574 |
I/I |
(2,913) |
175,500 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2022-08-19 |
4 |
S |
$33.22 |
$85,575 |
I/I |
(2,576) |
173,087 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-06-10 |
4 |
AS |
$18.62 |
$86,711 |
D/D |
(4,617) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2024-01-10 |
4 |
AS |
$19.02 |
$88,785 |
D/D |
(4,668) |
147,794 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2018-12-03 |
4/A |
OE |
$5.28 |
$92,400 |
I/I |
17,500 |
195,625 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2022-02-11 |
4 |
S |
$34.71 |
$101,284 |
I/I |
(2,918) |
170,663 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-02-01 |
4 |
AS |
$18.64 |
$107,646 |
D/D |
(5,775) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-03 |
4/A |
AS |
$18.90 |
$109,148 |
I/I |
(5,775) |
178,125 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2021-02-09 |
4 |
S |
$74.40 |
$109,785 |
I/I |
(1,470) |
167,921 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-02 |
4/A |
AS |
$19.43 |
$112,937 |
I/I |
(5,775) |
178,125 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-02 |
4 |
AS |
$19.43 |
$112,937 |
I/I |
(5,775) |
142,615 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2020-09-10 |
4 |
AS |
$31.00 |
$114,359 |
I/I |
(3,689) |
165,141 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-04 |
4 |
AS |
$19.30 |
$118,084 |
D/D |
(5,950) |
2,777 |
0 |
- |
|
108 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
